| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Oncology Research, Centocor, Inc., Malvern, PA
Requests for reprints: Li Yan, Oncology Research, Centocor, Inc., 145 King of Prussia Road, Mail Stop R-4-2, Radnor, PA 19087. Phone: (610) 240-8108; Fax: (610) 889-4418. E-mail: LYan2{at}cntus.jnj.com
Matrix metalloproteinases (MMPs) are metal-dependent endopeptidases that play pivotal roles in tumor disease progression. In many solid tumors, MMPs are indeed produced by tumor stromal cells, rather than by tumor cells. This expression pattern is, at least in part, regulated by tumor-stroma interaction via tumor cell-associated extracellular matrix metalloproteinase inducer (EMMPRIN). In vitro, recombinant EMMPRIN dose-dependently stimulated MMP-1 production by primary human fibroblast cells. Interestingly, in addition to stimulating MMP expression, EMMPRIN also induced its own gene expression. To further explore this potential positive feedback regulatory mechanism, we generated human breast cancer cells expressing different levels of EMMPRIN. Coculture of EMMPRIN-positive tumor cells with fibroblast cells resulted in a concomitant stimulation of MMP-2, MMP-9, and EMMPRIN production. This induction was EMMPRIN dependent, was further enhanced by overexpression, and was reduced by antisense suppression of EMMPRIN expression in tumor cells. Increased expression of membrane-associated EMMPRIN was accompanied by an MMP-dependent generation of a soluble form of EMMPRIN representing a proteolytic cleavage product lacking the carboxyl terminus. On the basis of these findings, we propose a model in which tumor cell-associated EMMPRIN stimulates MMPs, as well as EMMPRIN expression in tumor stroma. Increased MMP activity in tumor local environment results in proteolytic cleavage of membrane-associated EMMPRIN, releasing soluble EMMPRIN. Soluble EMMPRIN in turn acts in a paracrine fashion on stroma cells that are both adjacent and distant to tumor sites to further stimulate the production of MMPs and additional EMMPRIN, which consequently contributes to tumor angiogenesis, tumor growth, and metastasis.
Key Words: cancer cleavage fibroblast cells extracellular matrix metalloproteinase inducer matrix metalloproteinase positive feedback proteinase remodeling stroma
This article has been cited by other articles:
![]() |
J. A. Zavadzkas, R. A. Plyler, S. Bouges, C. N. Koval, W. T. Rivers, C. U. Beck, E. I. Chang, R. E. Stroud, R. Mukherjee, and F. G. Spinale Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice Am J Physiol Heart Circ Physiol, October 1, 2008; 295(4): H1394 - H1402. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Huet, B. Vallee, D. Szul, F. Verrecchia, S. Mourah, J. V. Jester, T. Hoang-Xuan, S. Menashi, and E. E. Gabison Extracellular matrix metalloproteinase inducer/CD147 promotes myofibroblast differentiation by inducing {alpha}-smooth muscle actin expression and collagen gel contraction: implications in tissue remodeling FASEB J, April 1, 2008; 22(4): 1144 - 1154. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-Z. Ju, J.-M. Yang, X.-Y. Zhou, Z.-T. Li, and X.-H. Wu EMMPRIN Expression as a Prognostic Factor in Radiotherapy of Cervical Cancer Clin. Cancer Res., January 15, 2008; 14(2): 494 - 501. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sengupta and T. T. MacDonald The Role of Matrix Metalloproteinases in Stromal/Epithelial Interactions in the Gut Physiology, December 1, 2007; 22(6): 401 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, H.-Y. Xu, Q. Zhang, F. Song, J.-L. Jiang, X.-M. Yang, L. Mi, N. Wen, R. Tian, L. Wang, et al. HAb18G/CD147 Functions in Invasion and Metastasis of Hepatocellular Carcinoma Mol. Cancer Res., June 1, 2007; 5(6): 605 - 614. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gallagher, J. J. Castorino, D. Wang, and N. J. Philp Monocarboxylate Transporter 4 Regulates Maturation and Trafficking of CD147 to the Plasma Membrane in the Metastatic Breast Cancer Cell Line MDA-MB-231 Cancer Res., May 1, 2007; 67(9): 4182 - 4189. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zheng, K. Tsuneyama, C. Cheng, H. Takahashi, Z. Cui, K. Nomoto, Y. Murai, and Y. Takano Expression of KAI1 and tenascin, and microvessel density are closely correlated with liver metastasis of gastrointestinal adenocarcinoma J. Clin. Pathol., January 1, 2007; 60(1): 50 - 56. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Egawa, N. Koshikawa, T. Tomari, K. Nabeshima, T. Isobe, and M. Seiki Membrane Type 1 Matrix Metalloproteinase (MT1-MMP/MMP-14) Cleaves and Releases a 22-kDa Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Fragment from Tumor Cells J. Biol. Chem., December 8, 2006; 281(49): 37576 - 37585. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, J. Lin, T. Kanekura, J. Su, W. Lin, H. Xie, Y. Wu, J. Li, M. Chen, and J. Chang A Small Interfering CD147-Targeting RNA Inhibited the Proliferation, Invasiveness, and Metastatic Activity of Malignant Melanoma Cancer Res., December 1, 2006; 66(23): 11323 - 11330. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tang, M. T. Nakada, P. Rafferty, J. Laraio, F. L. McCabe, H. Millar, M. Cunningham, L. A. Snyder, P. Bugelski, and L. Yan Regulation of Vascular Endothelial Growth Factor Expression by EMMPRIN via the PI3K-Akt Signaling Pathway Mol. Cancer Res., June 1, 2006; 4(6): 371 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. G. Braundmeier, A. T. Fazleabas, B. A. Lessey, H. Guo, B. P. Toole, and R. A. Nowak Extracellular Matrix Metalloproteinase Inducer Regulates Metalloproteinases in Human Uterine Endometrium J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2358 - 2365. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Yang, P. O'Neill, W. Jin, R. Foty, D. J. Medina, Z. Xu, M. Lomas, G. M. Arndt, Y. Tang, M. Nakada, et al. Extracellular Matrix Metalloproteinase Inducer (CD147) Confers Resistance of Breast Cancer Cells to Anoikis through Inhibition of Bim J. Biol. Chem., April 7, 2006; 281(14): 9719 - 9727. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Kamat, M. Fletcher, L. M. Gruman, P. Mueller, A. Lopez, C. N. Landen Jr., L. Han, D. M. Gershenson, and A. K. Sood The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer Clin. Cancer Res., March 15, 2006; 12(6): 1707 - 1714. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Lewis and J. W. Pollard Distinct Role of Macrophages in Different Tumor Microenvironments Cancer Res., January 15, 2006; 66(2): 605 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Hagemann, J. Wilson, H. Kulbe, N. F. Li, D. A. Leinster, K. Charles, F. Klemm, T. Pukrop, C. Binder, and F. R. Balkwill Macrophages Induce Invasiveness of Epithelial Cancer Cells Via NF-{kappa}B and JNK J. Immunol., July 15, 2005; 175(2): 1197 - 1205. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. McDonnel Smedts and T.E. Curry Jr. Expression of Basigin, an Inducer of Matrix Metalloproteinases, in the Rat Ovary Biol Reprod, July 1, 2005; 73(1): 80 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tang, M. T. Nakada, P. Kesavan, F. McCabe, H. Millar, P. Rafferty, P. Bugelski, and L. Yan Extracellular Matrix Metalloproteinase Inducer Stimulates Tumor Angiogenesis by Elevating Vascular Endothelial Cell Growth Factor and Matrix Metalloproteinases Cancer Res., April 15, 2005; 65(8): 3193 - 3199. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Laurent-Matha, S. Maruani-Herrmann, C. Prebois, M. Beaujouin, M. Glondu, A. Noel, M. L. Alvarez-Gonzalez, S. Blacher, P. Coopman, S. Baghdiguian, et al. Catalytically inactive human cathepsin D triggers fibroblast invasive growth J. Cell Biol., January 31, 2005; 168(3): 489 - 499. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Gabison, S. Mourah, E. Steinfels, L. Yan, T. Hoang-Xuan, M. A. Watsky, B. De Wever, F. Calvo, A. Mauviel, and S. Menashi Differential Expression of Extracellular Matrix Metalloproteinase Inducer (CD147) in Normal and Ulcerated Corneas: Role in Epithelio-Stromal Interactions and Matrix Metalloproteinase Induction Am. J. Pathol., January 1, 2005; 166(1): 209 - 219. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Pellikainen, K. M. Ropponen, V. V. Kataja, J. K. Kellokoski, M. J. Eskelinen, and V.-M. Kosma Expression of Matrix Metalloproteinase (MMP)-2 and MMP-9 in Breast Cancer with a Special Reference to Activator Protein-2, HER2, and Prognosis Clin. Cancer Res., November 15, 2004; 10(22): 7621 - 7628. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Haug, C. Lenz, F. Diaz, and M. G. Bachem Oxidized Low-Density Lipoproteins Stimulate Extracellular Matrix Metalloproteinase Inducer (EMMPRIN) Release by Coronary Smooth Muscle Cells Arterioscler. Thromb. Vasc. Biol., October 1, 2004; 24(10): 1823 - 1829. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |